Moderna will slash five clinical programmes but says it remains on track for ten...
The data from two Phase III trials demonstrated GLP-1/glucagon agonist’s efficac...
Distribution of the self-amplifying mRNA vaccine Kostaive is set to align with a...
Terns Pharmaceuticals’ decision to move away from the liver disease field may tu...
Relay Therapeutics released interim Phase I/II data showing that RLY-2608, its i...
Viridian announced that veligrotug, its potential thyroid eye disease (TED) drug...
Brightflow SAS, a privately owned company at the forefront in the area of long-t...
Genesis Therapeutics’ AI drug discovery platform, GEMS, has gained popularity an...
Eli Lilly’s insulin candidate efsitora alfa has achieved its main goals in a fur...
Sanofi has announced the inauguration its new modular vaccine and biomedicine pr...
Gilead Sciences has partnered with Genesis Therapeutics to discover and develop ...
As the approval date for Bristol Myers Squibb’s schizophrenia drug KarXT looms, ...
The FDA has granted breakthrough therapy designation to Neuraptive Therapeutics’...
Johnson & Johnson has announced that the US FDA has approved TREMFYA for the tre...
EASD 2024 participants are looking for the hottest efficacy data to make predict...
The IBA-SCK CEN joint venture secured funds to increase production of the radioi...
